{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"46.95","value":"12.4"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"54.34","value":"11.4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"258"},{"groupId":"OG001","value":"256"}],"units":"Participants"}],"description":"Time from randomisation until the date of discontinuation of randomised treatment for any reason","dispersionType":"Full Range","groups":[{"description":"Fulvestrant 250 mg Loading Dose Regimen + Anastrozole 1 mg","id":"OG000","title":"Fulvestrant + Anastrozole"},{"description":"Anastrozole 1 mg","id":"OG001","title":"Anastrozole"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"From randomisation until data cut-off on 30th April 2009","title":"Time to Treatment Failure (TTF)","type":"SECONDARY","unitOfMeasure":"months"}